42239-001-66 : NDC 2026 Code

42239-001-66 : Atovaquone ( Atovaquone )

Additionally :

You can get information about “42239-001-66” NDC code in 42239-001-66 in HTML format

HTML | 42239-001-66 in TXT (Plain Text) format

TXT | 42239-001-66 in PDF (Portable Document Format)

PDF | 42239-001-66 in XML format

XML formats.

NDC Code : 42239-001-66 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "42239-001-66",
    "PackageDescription": "6 CUP, UNIT-DOSE in 1 TRAY (42239-001-66)  / 5 mL in 1 CUP, UNIT-DOSE (42239-001-17) ",
    "NDC11Code": "42239-0001-66",
    "ProductNDC": "42239-001",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Atovaquone",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Atovaquone",
    "DosageFormName": "SUSPENSION",
    "RouteName": "ORAL",
    "StartMarketingDate": "20231114",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA214272",
    "LabelerName": "Abon Pharmaceuticals, LLC",
    "SubstanceName": "ATOVAQUONE",
    "StrengthNumber": "750",
    "StrengthUnit": "mg/5mL",
    "Pharm_Classes": "Antimalarial [EPC], Antiprotozoal [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-05-13",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250501",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}